Reed-Lane has officially entered the cold supply chain market with the opening of its first controlled cold storage at its Wayne, NJ packaging facility.
Among Reed-Lane’s reasons for entering the cold chain market is the strong growth of the biologics industry, whose high-value products often place added emphasis on proper, tightly-controlled storage environments. Maintaining a secure cold chain through the storage, handling and transportation of temperature-sensitive drugs assures product quality and integrity, benefitting patients and keeping manufacturers, hospitals and pharmacists in compliance with various laws, regulations, guidelines and codes.
“With the introduction of our new cold storage, Reed-Lane shows its continued commitment to expanded capabilities as we reach further into the pharma and biopharma markets,” said Patricia Elvin, President of Reed-Lane. “This venture, along with our investment in systems that enable us to achieve unit-level to full-aggregation serialization, puts us in a position to serve our valued pharmaceutical customers with the tremendous speed, efficiency and flexibility for which we are known.”